Skip to content
Brand AI

Diovan

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2026

    Novartis recalls Diovan valsartan batch over dissolution specification failure

    Novartis recalled a specific batch of its Diovan (valsartan) blood pressure drug after it failed to meet dissolution specifications, potentially reducing effectiveness. The FDA classified the notice as a Class II recall, warning of possible temporary or medically reversible adverse health consequences. The affected batch, marked AV5913C, consists of 90-count 160-mg tablets expiring June 2027, manufactured by Pantheon Manufacturing Services in Greenville, North Carolina and distributed nationwide in the US.

    Source